Corium International Company Profile (NASDAQ:CORI)

About Corium International

Corium International logoCorium International, Inc. is a biopharmaceutical company. The Company is engaged in the development, manufacture and commercialization of specialty pharmaceutical products that focuses on transdermal and transmucosal delivery systems. Its development platforms enable transdermal delivery of large molecules, or biologics, including vaccines, peptides and proteins, as well as small molecules. Its Corplex and MicroCor platforms address the shortcomings of traditional transdermal drug delivery. Its marketed products include Clonidine TDS, which is a treatment for hypertension; Fentanyl TDS, which is a treatment for management of chronic pain, and Crest Whitestrips are a series of five products for oral care. Its Twirla is designed to deliver both hormones at levels comparable to low-dose oral contraceptives. Its MicroCor hPTH(1‑34) is a transdermal system designed to use its MicroCor technology to provide the delivery of parathyroid hormone.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CORI
  • CUSIP:
Key Metrics:
  • Previous Close: $6.00
  • 50 Day Moving Average: $5.55
  • 200 Day Moving Average: $4.49
  • 52-Week Range: $3.14 - $10.50
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.14
  • P/E Growth: 0.00
  • Market Cap: $134.15M
  • Outstanding Shares: 22,359,000
  • Beta: 1.02
Profitability:
  • Net Margins: -104.77%
  • Return on Equity: -158.38%
  • Return on Assets: -41.25%
Debt:
  • Debt-to-Equity Ratio: 4.59%
  • Current Ratio: 6.98%
  • Quick Ratio: 6.62%
Additional Links:
Companies Related to Corium International:

Analyst Ratings

Consensus Ratings for Corium International (NASDAQ:CORI) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $13.40 (124.83% upside)
Analysts' Ratings History for Corium International (NASDAQ:CORI)
Show:
DateFirmActionRatingPrice TargetDetails
9/26/2016Needham & Company LLCReiterated RatingBuy$15.00View Rating Details
8/5/2016FBR & CoSet Price TargetBuy$18.00View Rating Details
5/18/2016Leerink SwannReiterated RatingBuy$14.00View Rating Details
5/11/2016Jefferies GroupReiterated RatingBuy$9.00View Rating Details
5/3/2016WBB SecuritiesUpgradeHold -> Speculative Buy$11.00View Rating Details
6/9/2015GuggenheimInitiated CoverageBuy$18.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Corium International (NASDAQ:CORI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/4/2016Q3($0.42)($0.34)ViewN/AView Earnings Details
5/10/2016Q2($0.37)($0.47)ViewListenView Earnings Details
2/8/2016Q1($0.35)($0.42)ViewN/AView Earnings Details
11/12/2015Q4($0.45)($0.42)ViewListenView Earnings Details
2/10/2015Q115($0.24)($0.37)$10.42 million$9.77 millionViewN/AView Earnings Details
11/17/2014($0.32)($0.51)ViewN/AView Earnings Details
8/12/2014($0.17)($0.28)ViewN/AView Earnings Details
5/14/2014($0.18)($0.24)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Corium International (NASDAQ:CORI)
Current Year EPS Consensus Estimate: $-1.62 EPS
Next Year EPS Consensus Estimate: $-1.16 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.38)($0.38)($0.38)
Q2 20161($0.35)($0.35)($0.35)
Q3 20163($0.43)($0.41)($0.42)
Q4 20163($0.46)($0.30)($0.38)
Q1 20171($0.31)($0.31)($0.31)
Q2 20171($0.34)($0.34)($0.34)
Q3 20171($0.32)($0.32)($0.32)
Q4 20171($0.29)($0.29)($0.29)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Corium International (NASDAQ:CORI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Corium International (NASDAQ:CORI)
Insider Ownership Percentage: 45.70%
Institutional Ownership Percentage: 88.15%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/19/2016Eric BjerkholtDirectorBuy24,500$3.64$89,180.00View SEC Filing  
5/12/2016David GreenwoodDirectorBuy3,000$3.58$10,740.00View SEC Filing  
2/25/2015Peter D StapleCEOBuy3,600$6.99$25,164.00View SEC Filing  
11/24/2014Robert S BreuilCFOBuy4,600$5.38$24,748.00View SEC Filing  
11/21/2014Peter D StapleCEOBuy9,000$5.34$48,060.00View SEC Filing  
8/27/2014Peter D StapleCEOBuy2,578$6.10$15,725.80View SEC Filing  
5/30/2014Peter D StapleCEOBuy7,200$7.04$50,688.00View SEC Filing  
4/8/2014Woodlands Health Venture EssexMajor ShareholderBuy400,000$8.00$3,200,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Corium International (NASDAQ:CORI)
DateHeadline
bizjournals.com logoThe tech behind Crest Whitestrips could help Alzheimer's patients (NASDAQ:CORI)
www.bizjournals.com - August 29 at 9:01 AM
finance.yahoo.com logoCorium International (CORI) Jumps: Stock Moves Up 6.9% (NASDAQ:CORI)
finance.yahoo.com - August 26 at 10:43 AM
bizjournals.com logoHow the tech behind Crest Whitestrips could help Alzheimer's patients (NASDAQ:CORI)
feeds.bizjournals.com - August 25 at 6:21 PM
News IconSigma Labs Announces Launch of PrintRite3D® INSPECT™ Software v1.3.2 and Upcoming Industry Events (NASDAQ:CORI)
www.econotimes.com - August 24 at 9:57 AM
publicnow.com logoCorium Announces Streamlined Bioequivalence Development Path for Transdermal Corplex™ Memantine (NASDAQ:CORI)
www.publicnow.com - August 24 at 9:57 AM
capitalcube.com logoETF’s with exposure to Corium International, Inc. : August 23, 2016 (NASDAQ:CORI)
www.capitalcube.com - August 23 at 4:28 PM
finance.yahoo.com logoEdited Transcript of CORI earnings conference call or presentation 4-Aug-16 9:00pm GMT (NASDAQ:CORI)
finance.yahoo.com - August 19 at 3:26 PM
finance.yahoo.com logoCORIUM INTERNATIONAL, INC. Financials (NASDAQ:CORI)
finance.yahoo.com - August 19 at 3:26 PM
capitalcube.com logoCorium International, Inc. :CORI-US: Earnings Analysis: Q3, 2016 By the Numbers : August 11, 2016 (NASDAQ:CORI)
www.capitalcube.com - August 11 at 11:20 AM
twst.com logoCorium International Inc.: Corium Reports Third Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights (NASDAQ:CORI)
www.twst.com - August 4 at 10:02 PM
sg.finance.yahoo.com logoCorium reports 3Q loss (NASDAQ:CORI)
sg.finance.yahoo.com - August 4 at 10:02 PM
publicnow.com logoCorium Reports Third Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights (NASDAQ:CORI)
www.publicnow.com - August 4 at 4:32 PM
biz.yahoo.com logoQ3 2016 Corium International Inc Earnings Release - After Market Close (NASDAQ:CORI)
biz.yahoo.com - August 4 at 11:14 AM
capitalcube.com logoETF’s with exposure to Corium International, Inc. : July 29, 2016 (NASDAQ:CORI)
www.capitalcube.com - July 29 at 1:21 PM
publicnow.com logoCorium to Report Third Quarter Fiscal Year 2016 Financial Results on Thursday, August 4, 2016 (NASDAQ:CORI)
www.publicnow.com - July 28 at 8:18 AM
publicnow.com logoCorium Presents Full Clinical Results from Phase 1 Pharmacokinetic Study of Once-weekly Corplex™ Donepezil Transdermal System (NASDAQ:CORI)
www.publicnow.com - July 27 at 4:18 PM
finance.yahoo.com logoCan The Uptrend Continue for Corium International (CORI)? (NASDAQ:CORI)
finance.yahoo.com - July 27 at 9:57 AM
finance.yahoo.com logoCorium to Present Clinical Data from a Phase 1 Pharmacokinetic Study of Once-Weekly Corplex™ Donepezil Transdermal System (NASDAQ:CORI)
finance.yahoo.com - July 20 at 4:03 PM
publicnow.com logoCorium to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:CORI)
www.publicnow.com - July 5 at 4:31 PM
finance.yahoo.com logoCorium to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:CORI)
finance.yahoo.com - July 5 at 4:21 PM
marketwatch.com logoImpetigo Pipeline H1 2016 Reviewed for Global Markets (NASDAQ:CORI)
www.marketwatch.com - June 23 at 10:40 AM
capitalcube.com logoETF’s with exposure to Corium International, Inc. : June 20, 2016 (NASDAQ:CORI)
www.capitalcube.com - June 20 at 2:15 PM
4-traders.com logoCORIUM INTERNATIONAL, INC. : Costs Associated with Exit or Disposal Activities (form 8-K) (NASDAQ:CORI)
www.4-traders.com - June 16 at 9:39 PM
biz.yahoo.com logoCORIUM INTERNATIONAL, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities (NASDAQ:CORI)
biz.yahoo.com - June 15 at 5:05 PM
capitalcube.com logoCorium International, Inc. :CORI-US: Earnings Analysis: Q2, 2016 By the Numbers : June 7, 2016 (NASDAQ:CORI)
www.capitalcube.com - June 7 at 11:08 AM
finance.yahoo.com logoGlobal Obesity Pipeline Report H1 2016 - Review of 98 Companies & Drug Profiles - Research and Markets (NASDAQ:CORI)
finance.yahoo.com - June 4 at 12:51 PM
publicnow.com logoCorium to Present at the Jefferies 2016 Healthcare Conference (NASDAQ:CORI)
www.publicnow.com - May 25 at 4:26 PM
biz.yahoo.com logoCORIUM INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:CORI)
biz.yahoo.com - May 13 at 4:08 PM
finance.yahoo.com logoEdited Transcript of CORI earnings conference call or presentation 10-May-16 9:00pm GMT (NASDAQ:CORI)
finance.yahoo.com - May 12 at 7:55 AM
sg.finance.yahoo.com logoCorium reports 2Q loss (NASDAQ:CORI)
sg.finance.yahoo.com - May 10 at 6:06 PM
publicnow.com logoCorium Reports Second Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights (NASDAQ:CORI)
www.publicnow.com - May 10 at 4:28 PM
biz.yahoo.com logoQ2 2016 Corium International Inc Earnings Release - After Market Close (NASDAQ:CORI)
biz.yahoo.com - May 10 at 7:07 AM
finance.yahoo.com logoCorium International (CORI) Jumps: Stock Moves 9.5% Higher (NASDAQ:CORI)
finance.yahoo.com - May 4 at 8:15 AM
publicnow.com logoCorium to Report Second Quarter Fiscal Year 2016 Financial Results on Tuesday, May 10, 2016 (NASDAQ:CORI)
www.publicnow.com - May 3 at 4:20 PM
finance.yahoo.com logoCorium International upgraded by WBB Securities (NASDAQ:CORI)
finance.yahoo.com - May 3 at 8:41 AM
capitalcube.com logoETF’s with exposure to Corium International, Inc. : April 14, 2016 (NASDAQ:CORI)
www.capitalcube.com - April 14 at 3:00 PM
capitalcube.com logoCorium International, Inc. :CORI-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:CORI)
www.capitalcube.com - April 6 at 11:58 AM
publicnow.com logoCorium to Present at 15th Annual Needham Healthcare Conference (NASDAQ:CORI)
www.publicnow.com - March 31 at 8:09 AM
publicnow.com logoCorium Announces Positive Preclinical Results with Long-acting Potent GLP-1 Analog Delivered in MicroCor® Transdermal Patch (NASDAQ:CORI)
www.publicnow.com - March 29 at 4:13 PM
thestreet.com logoAnalysts Expect UWM Will Reach $84 (NASDAQ:CORI)
www.thestreet.com - March 19 at 2:06 PM
biz.yahoo.com logoCORIUM INTERNATIONAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:CORI)
biz.yahoo.com - March 9 at 4:07 PM
finance.yahoo.com logoCorium International (CORI) in Focus: Stock Moves Up 8.5% (NASDAQ:CORI)
finance.yahoo.com - February 23 at 8:15 AM
finance.yahoo.com logoCorium Announces Positive Topline Results From Phase 1 Clinical Study of Transdermal Corplex™ Memantine as a Potential Treatment of Alzheimer’s Disease (NASDAQ:CORI)
finance.yahoo.com - February 22 at 4:03 PM
biz.yahoo.com logoCORIUM INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:CORI)
biz.yahoo.com - February 12 at 4:38 PM
biz.yahoo.com logoCORIUM INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (NASDAQ:CORI)
biz.yahoo.com - February 8 at 4:14 PM
sg.finance.yahoo.com logoCorium reports 1Q loss (NASDAQ:CORI)
sg.finance.yahoo.com - February 8 at 4:14 PM
finance.yahoo.com logoCorium Reports First Quarter Fiscal 2016 Financial Results (NASDAQ:CORI)
finance.yahoo.com - February 8 at 4:03 PM
biz.yahoo.com logoQ1 2016 Corium International Inc Earnings Release - After Market Close (NASDAQ:CORI)
biz.yahoo.com - February 8 at 7:07 AM
finance.yahoo.com logoCorium International (CORI) Jumps: Stock Moves Up 8.9% (NASDAQ:CORI)
finance.yahoo.com - February 5 at 8:15 AM
finance.yahoo.com logo4:04 pm Corium International announces positive topline results from Phase 1 study of once-weekly transdermal Corplex Donepezil as a potential treatment of Alzheimer's disease (NASDAQ:CORI)
finance.yahoo.com - February 3 at 4:04 PM

Social

Corium International (NASDAQ:CORI) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff